# Red Light Photobiomodulation and Topical Disinfectants

> **NCT05797818** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ondine Biomedical Inc.** · enrollment: 28 (actual)

## Conditions studied

- Healthcare Associated Infection
- Nosocomial Infection
- Surgical Site Infection

## Interventions

- **DEVICE:** Methylene Blue Only
- **DEVICE:** Chlorhexidine Gluconate Only
- **DEVICE:** Methylene Blue + Chlorhexidine Gluconate
- **DEVICE:** Light Only

## Key facts

- **NCT ID:** NCT05797818
- **Lead sponsor:** Ondine Biomedical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-10
- **Primary completion:** 2023-02-08
- **Final completion:** 2023-02-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05797818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05797818, "Red Light Photobiomodulation and Topical Disinfectants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05797818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*